Meridia Risk Management Program Strengthened

New patient leaflet and revised labeling highlights the risk profile of Abbott's obesity drug. The risk of a "large increase in blood pressure or heart rate" is "the most important information you should know about Meridia," leaflet says. Thirty-count bottles also approved.